Q&A11 Jun 2020 15:51
Some good questions:
Manufacturing of Affirmers, easy to transfer out for scaling up
Coming weeks and months - lots of news flow, cytiva, manufacturers for lateral flow, other commercial partners for different test, potential for inhibitors deal, basically loads of options for news flow
sounds good to me. There's always risk involved, surely when you DYOR and invest you take that into account
GLA